menu search

Spero therapeutics shares rise on fda approval of pivotal complicated uti trial

Spero Therapeutics shares soared after the clinical-stage biopharmaceutical company announced that it has received special protocol approval from the ...

July 31, 2023, 3:42 pm

Spero therapeutics announces special protocol assessment agreement with fda for phase 3 pivot-po trial of tebipenem hbr

Phase 3 PIVOT-PO trial is expected to begin with First Patient, First Visit in 4Q 2023 Spero to receive $30 million development milestone payment from...

July 31, 2023, 12:05 pm

Spero therapeutics: the multi-asset pipeline could outpace the tebipenem hbr deal with gsk

Spero is eligible to receive up to $525 million in development and sales milestone payments as well as royalties on net product sales under the agreem...

July 5, 2023, 3:06 pm


Search within

Pages Search Results: